Imatinib Mesylate (Gleevec)

DRUG5 trials

Conditions

Acute Myelogenous LeukemiaAgnogenic Myeloid MetaplasiaChronic Myelogenous LeukemiaChronic Myeloid LeukemiaChronic Myelomonocytic LeukemiaGastrointestinal Stromal TumorsHypereosinophilic SyndromeIdiopathic Pulmonary Fibrosis

Phase 1

Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia

CompletedNCT00047502

M.D. Anderson Cancer CenterChronic Myelogenous Leukemia

Start: 2002-11-01End: 2006-04-10Updated: 2018-11-07

PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP

CompletedNCT00088231

M.D. Anderson Cancer CenterAcute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Chronic Myelogenous Leukemia

Start: 2004-07-31End: 2006-10-31Updated: 2012-01-20

Phase 2

Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study

CompletedNCT00131274

Daniels, Craig E., M.D.Idiopathic Pulmonary Fibrosis, Lung Disease, Pulmonary Fibrosis

Start: 2003-04-30End: 2007-08-31Target: 120Updated: 2005-10-05

Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST

CompletedNCT00500188

M.D. Anderson Cancer CenterGastrointestinal Stromal Tumors

Start: 2003-07-31End: 2011-07-31Updated: 2011-08-08

Unknown Phase

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

CompletedNCT00038675

M.D. Anderson Cancer CenterChronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Hypereosinophilic Syndrome +2

Start: 2001-06-30End: 2013-11-30Updated: 2022-01-04

Related Papers

An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis

ERJ Open Research2024-01-013 citations

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.